Heska Corp. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
939.00
1,599.00
5,519.00
12,165.00
9,456.00
5,850
Depreciation, Depletion & Amortization
2,497.00
3,712.00
4,187.00
4,645.00
4,754.00
4,595
Other Funds
-
-
1,514.00
-
965.00
5,307
Funds from Operations
1,185.00
8,415.00
13,338.00
22,999.00
25,773.00
13,497
Changes in Working Capital
2,582.00
2,633.00
11,213.00
17,144.00
15,364.00
210
Net Operating Cash Flow
1,397.00
5,782.00
2,125.00
5,855.00
10,409.00
13,287
Capital Expenditures
1,930.00
2,337.00
3,773.00
3,417.00
3,469.00
Sale of Fixed Assets & Businesses
5,020.00
6.00
-
-
57.00
Purchase/Sale of Investments
-
-
-
115.00
-
Net Investing Cash Flow
71.00
2,331.00
3,773.00
3,302.00
17,169.00
Issuance/Reduction of Debt, Net
1,221.00
4,929.00
46.00
217.00
5,140.00
Net Financing Cash Flow
1,544.00
3,499.00
2,726.00
1,403.00
5,551.00
Net Change in Cash
232.00
162.00
1,035.00
3,904.00
1,135.00
Free Cash Flow
3,327.00
3,445.00
1,648.00
2,438.00
6,940.00
Deferred Taxes & Investment Tax Credit
637.00
1,304.00
1,327.00
3,932.00
8,864.00
2,255
Net Assets from Acquisitions
3,019.00
-
-
-
13,757.00
Change in Capital Stock
323.00
1,430.00
1,258.00
1,620.00
1,376.00
Exchange Rate Effect
14.00
114.00
43.00
52.00
74.00

About Heska

View Profile
Address
3760 Rocky Mountain Avenue
Loveland Colorado 80538
United States
Employees -
Website http://www.heska.com
Updated 07/08/2019
Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through the Core Companion Animal Health; and Other Vaccines, and Pharmaceuticals and Products segments. The Core Companion Animal Health segment includes point of care diagnostic laboratory instruments and supplies, imaging instruments, software, and services as well as single use diagnostic and other tests, pharmaceuticals, and vaccines.